DK0593491T3 - Luteiniseringshormonfrigørende hormonantagonistpeptider - Google Patents

Luteiniseringshormonfrigørende hormonantagonistpeptider

Info

Publication number
DK0593491T3
DK0593491T3 DK92906562.1T DK92906562T DK0593491T3 DK 0593491 T3 DK0593491 T3 DK 0593491T3 DK 92906562 T DK92906562 T DK 92906562T DK 0593491 T3 DK0593491 T3 DK 0593491T3
Authority
DK
Denmark
Prior art keywords
pct
hormone
antagonist peptides
sec
luteinization
Prior art date
Application number
DK92906562.1T
Other languages
English (en)
Inventor
Romano Deghenghi
Original Assignee
Romano Deghenghi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romano Deghenghi filed Critical Romano Deghenghi
Application granted granted Critical
Publication of DK0593491T3 publication Critical patent/DK0593491T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92906562.1T 1991-04-25 1992-03-17 Luteiniseringshormonfrigørende hormonantagonistpeptider DK0593491T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69086191A 1991-04-25 1991-04-25

Publications (1)

Publication Number Publication Date
DK0593491T3 true DK0593491T3 (da) 1997-03-17

Family

ID=24774274

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92906562.1T DK0593491T3 (da) 1991-04-25 1992-03-17 Luteiniseringshormonfrigørende hormonantagonistpeptider

Country Status (12)

Country Link
US (1) US5516887A (da)
EP (1) EP0593491B1 (da)
JP (1) JP2719233B2 (da)
AT (1) ATE144538T1 (da)
AU (1) AU1371892A (da)
CA (1) CA2108977C (da)
DE (2) DE593491T1 (da)
DK (1) DK0593491T3 (da)
ES (1) ES2052488T3 (da)
GR (2) GR940300048T1 (da)
HK (1) HK1006172A1 (da)
WO (1) WO1992019651A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284854B1 (en) * 1991-07-05 2001-09-04 Biccompatibles Limited Polymeric surface coatings
US6225431B1 (en) * 1991-07-05 2001-05-01 Biocompatibles Limited Biocompatibilizing process
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
US5925730A (en) 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
JP2002512976A (ja) * 1998-04-27 2002-05-08 プレーシス ファーマスーティカルズ インコーポレイテッド のぼせおよび女性化乳房を処置するための方法
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
US6703367B1 (en) * 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
CN1443195A (zh) 2000-03-14 2003-09-17 赞塔里斯股份公司 新型lhrh拮抗剂,其制备方法和药物用途
WO2002002144A1 (fr) * 2000-07-05 2002-01-10 Takeda Chemical Industries, Ltd. Preparations medicinales pour le traitement des maladies dependant des hormones sexuelles
GB0117057D0 (en) * 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
US7098305B2 (en) 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1778278B1 (en) 2004-07-16 2014-05-21 Oakwood Laboratories L.L.C. Gonadotropin releasing hormone antagonists
TWI442932B (zh) 2008-02-11 2014-07-01 Ferring Int Ct Sa 以ＧｎＲＨ拮抗劑治療攝護腺癌的方法
TWI508734B (zh) * 2009-05-01 2015-11-21 Ferring Int Ct Sa 用於前列腺癌之治療的組成物
TW201043221A (en) * 2009-05-06 2010-12-16 Ferring Int Ct Sa Kit and method for preparation of a Degarelix solution
US20110039787A1 (en) * 2009-07-06 2011-02-17 Ferring International Center S.A. Compositions, kits and methods for treating benign prostate hyperplasia
EP2447276A1 (en) 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
ES2617336T3 (es) 2010-10-27 2017-06-16 Ferring B.V. Procedimiento para la fabricación de degarelix y sus productos intermedios
JO3755B1 (ar) 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
JP6226966B2 (ja) 2012-06-01 2017-11-08 フェリング ベスローテン フェンノートシャップ デガレリクスの製造
MX389242B (es) 2015-06-15 2025-03-20 Nmd Pharma As Compuestos para su uso en el tratamiento de trastornos neuromusculares
US12440477B2 (en) 2017-12-14 2025-10-14 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
CN113527438A (zh) * 2021-08-30 2021-10-22 湖南三太药业有限公司 一种全液相合成丙氨瑞林的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740500A (en) * 1985-01-31 1988-04-26 The Salk Institute For Biological Studies GnRH antagonists VIII
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs

Also Published As

Publication number Publication date
US5516887A (en) 1996-05-14
DE593491T1 (de) 1994-11-17
EP0593491A1 (en) 1994-04-27
DE69214818D1 (de) 1996-11-28
WO1992019651A1 (en) 1992-11-12
ES2052488T1 (es) 1994-07-16
ATE144538T1 (de) 1996-11-15
CA2108977A1 (en) 1992-10-26
ES2052488T3 (es) 1997-01-01
JP2719233B2 (ja) 1998-02-25
EP0593491B1 (en) 1996-10-23
CA2108977C (en) 2002-12-17
HK1006172A1 (en) 1999-02-12
AU1371892A (en) 1992-12-21
GR940300048T1 (en) 1994-07-29
JPH06507604A (ja) 1994-09-01
DE69214818T2 (de) 1997-02-27
GR3022144T3 (en) 1997-03-31

Similar Documents

Publication Publication Date Title
ES2052488T1 (es) Peptidos antagonistas de la hormona liberadora de hormona luteinizante.
MX9304577A (es) Composicion de enmascaramiento del sabor de agentes farmaceuticos amargos.
ATE288444T1 (de) Dipeptide, die die ausschüttung von wachstumshormonen stimulieren
DE69620241D1 (de) Gonadotropin releasing hormon- antagonisten
ATE269103T1 (de) Stabilisierte wässerige glukagonlösungen enthaltend detergenzien
MD1699F2 (ro) Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei
ES2137257T3 (es) Jeringa de una sola inyeccion.
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
TW200626613A (en) Analogues of GLP-1
FR2656928B1 (fr) Dispositif ameliore d'immunotest du type plaquette a plonger, et trousse contenant ce dispositif.
LU91342I9 (da)
TR199901669T2 (xx) Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod.
IT8022519A0 (it) Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante.
ATE149525T1 (de) Galaninantagonist
ES2131528T3 (es) Nuevos polipeptidos y su uso.
SE9402880D0 (sv) New peptide derivatives
MX9308014A (es) Peptidos antagonistas de la hormona liberadora de la hormona luteinizante.
NO912271L (no) Somatostatinpreparater, deres fremstilling og anvendelse.
FI935191A0 (fi) Peptidfoereningar, speciellt LHRH-antagonister
FR2674633B1 (fr) Circuit de detection d'un seuil haut d'une tension d'alimentation.
FI923448A7 (fi) Non-A, non-B-peptidi
DK0663832T3 (da) Anvendelse af 4'-iod-4'-deoxydoxorubicin til behandling af amyloidose
SE8501202D0 (sv) Human intestinal hormone and its use
ES2094930T3 (es) Nueva proteina inhibidora de trombina aislada de garrapatas.